Gastrointestinal microbiota in irritable bowel syndrome: present state and perspectives
Open accessThe DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Abstract
Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder that has been associated with aberrant microbiota. This review focuses on the recent molecular insights generated by analysing the intestinal microbiota in subjects suffering from IBS. Special emphasis is given to studies that compare and contrast the microbiota of healthy subjects with that of IBS patients classified into different subgroups based on their predominant bowel pattern as defined by the Rome criteria. The current data available from a limited number of patients do not reveal pronounced and reproducible IBS-related deviations of entire phylogenetic or functional microbial groups, but rather support the concept that IBS patients have alterations in the proportions of commensals with interrelated changes in the metabolic output and overall microbial ecology. The lack of apparent similarities in the taxonomy of microbiota in IBS patients may partially arise from the fact that the applied molecular methods, the nature and location of IBS subjects, and the statistical power of the studies have varied considerably. Most recent advances, especially the finding that several uncharacterized phylotypes show non-random segregation between healthy and IBS subjects, indicate the possibility of discovering bacteria specific for IBS. Moreover, tools are being developed for the functional analysis of the relationship between the intestinal microbiota and IBS. These approaches may be instrumental in the evaluation of the ecological dysbiosis hypothesis in the gut ecosystem. Finally, we discuss the future outlook for research avenues and candidate microbial biomarkers that may eventually be used in IBS diagnosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
A human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624 · cited 6×
“Recent metagenomic sequence analysis of the GI tract microbiota has confirmed this and defined a reference set of over three million unique genes that vastly exceeds the coding capacity of the human genome (Qin et al., 2010).”
BackgroundInfluentialA core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823 · cited 2×
“Comparative microbiota analyses between multiple healthy subjects indicate that a limited proportion of phylotypes are shared between individuals, forming a common core microbiota that is assumed to be functionally redundant (Qin et al., 2010; Tap et al., 2009; Turnbaugh et al., 2009).”
BackgroundWoese, C. R. (1987) · Microbiological Reviews · doi:10.1128/mr.51.2.221-271.1987 · Cited by 5,042 · cited 1×
“As the evolutionary distance of different bacterial phyla is comparable with that of animals and plants in the rRNA-based tree of life (Woese, 1987), the vast genetic and phenotypic heterogeneity of the taxa classified into a phylum makes the phylum-wide differences unlikely.”
BackgroundLongstreth, G. F., Thompson, W. G., Chey, W. D., Houghton, L. A., Mearin, F., & Spiller, R. C. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.061 · Cited by 4,856
Frank, D. N., St. Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., & Pace, N. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706625104 · Cited by 4,611 · cited 2×
“Interestingly, these taxa also stood out from clone libraries derived from IBD patients (Frank et al., 2007), and from an individual suffering from Clostridium difficile-associated disease (CDAD) with severe diarrhoea and colitis (Khoruts et al.”
BackgroundFunctional bowel disorders and functional abdominal pain
Thompson, W. G., Longstreth, G. F., Drossman, D. A., Heaton, K. W., Irvine, E. J., & Müller-Lissner, S. A. (1999) · Gut · doi:10.1136/gut.45.2008.ii43 · Cited by 2,440
Human gut microbiota in obesity and after gastric bypass
Zhang, H., DiBaise, J. K., Zuccolo, A., Kudrna, D., Braidotti, M., Yu, Y., Parameswaran, P., Crowell, M. D., Wing, R., Rittmann, B. E., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812600106 · Cited by 1,880 · cited 1×
“Recently, the increase of Erysipelotrichi has been associated with obesity (Zhang et al., 2009) as well as high fat intake (Fleissner et al.”
BackgroundLow counts of Faecalibacterium prausnitzii in colitis microbiota
Sokol, H., Seksik, P., Furet, J. P., Firmesse, O., Nion-Larmurier, I., Beaugerie, L., Cosnes, J., Corthier, G., Marteau, P., & Doré, J. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20903 · Cited by 1,275 · cited 1×
“In the case of inflammatory bowel diseases (IBDs), such an approach has uncovered significant differences in overall diversity as well as in specific bacteria (Qin et al., 2010; Sokol et al., 2009).”
BackgroundAre dental diseases examples of ecological catastrophes?
Marsh, P. D. (2003) · Microbiology · doi:10.1099/mic.0.26082-0 · Cited by 1,256 · cited 1×
“This synopsis strongly suggests homeostasis of the microbiota to be a critical element in the pathophysiology of IBS, in a manner analogous to the development of dental caries according to the proposed ecological plaque hypothesis (Marsh, 2003).”
BackgroundPostinfectious Irritable Bowel Syndrome
Spiller, R., & Garsed, K. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.02.074 · Cited by 1,024
Kassinen, A., Krogius-Kurikka, L., Mäkivuokko, H., Rinttilä, T., Paulin, L., Corander, J., Malinen, E., Apajalahti, J., & Palva, A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.005 · Cited by 1,002 · cited 8×
“Most of the observed differences could be assigned to the Firmicutes, as they dominate the significant alterations in the comparison of clone libraries (Kassinen et al., 2007; Krogius-Kurikka et al., 2009), microarray-derived microbiota profiles (Rajilić-Stojanović, 2007) and qPCR assays (Lyra et al.”
BackgroundMethodResultInfluentialSelf-citationTowards the human intestinal microbiota phylogenetic core
Tap, J., Mondot, S., Levenez, F., Pelletier, E., Caron, C., Furet, J., Ugarte, E., Muñoz‐Tamayo, R., Paslier, D. L. E., Nalin, R., et al. (2009) · Environmental Microbiology · doi:10.1111/j.1462-2920.2009.01982.x · Cited by 927 · cited 1×
“Comparative microbiota analyses between multiple healthy subjects indicate that a limited proportion of phylotypes are shared between individuals, forming a common core microbiota that is assumed to be functionally redundant (Qin et al., 2010; Tap et al., 2009; Turnbaugh et al., 2009).”
BackgroundSwidsinski, A., Weber, J., Loening-Baucke, V., Hale, L. P., & Lochs, H. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.7.3380-3389.2005 · Cited by 894 · cited 1×
“A fluorescence in situ hybridization (FISH) study showed unsubtyped IBS patients to harbour slightly more total bacteria and significantly more members of Clostridium cluster XIVa than the HCs (Swidsinski et al., 2005).”
BackgroundActivation of the mucosal immune system in irritable bowel syndrome
Chadwick, V. S., Chen, W., Shu, D., Paulus, B., Bethwaite, P., Tie, A., & Wilson, I. (2002) · Gastroenterology · doi:10.1053/gast.2002.33579 · Cited by 833
The role of pH in determining the species composition of the human colonic microbiota
Duncan, S. H., Louis, P., Thomson, J. M., & Flint, H. J. (2009) · Environmental Microbiology · doi:10.1111/j.1462-2920.2009.01931.x · Cited by 786 · cited 1×
“This finding suggests that addressing luminal conditions such as transit time and pH, known to critically influence the composition of the GI microbial community (Duncan et al., 2009; Louis et al., 2007), would be highly relevant in IBS and HCs, as we need to learn more about how the gut environment and related ecolog…”
BackgroundUnderstanding the effects of diet on bacterial metabolism in the large intestine
Louis, P., Scott, K. P., Duncan, S. H., & Flint, H. J. (2007) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2007.03322.x · Cited by 774 · cited 1×
“This finding suggests that addressing luminal conditions such as transit time and pH, known to critically influence the composition of the GI microbial community (Duncan et al., 2009; Louis et al., 2007), would be highly relevant in IBS and HCs, as we need to learn more about how the gut environment and related ecolog…”
BackgroundLouis, P., Young, P., Holtrop, G., & Flint, H. J. (2010) · Environmental Microbiology · doi:10.1111/j.1462-2920.2009.02066.x · Cited by 774 · cited 1×
“So far, the only described genespecific assays putatively relevant to IBS are the ones that target butyrate biogenesis (Louis et al., 2010) and the different H2 disposal routes discussed above (Nakamura et al.”
BackgroundThe efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review
Moayyedi, P., Ford, A. C., Talley, N. J., Cremonini, F., Foxx-Orenstein, A. E., Brandt, L. J., & Quigley, E. M. M. (2010) · Gut · doi:10.1136/gut.2008.167270 · Cited by 728 · cited 1×
“This aspect has also been recently reviewed (Moayyedi et al., 2010; Parkes et al., 2010; Pimentel & Lezcano, 2007) and will not be further discussed in this review.”
BackgroundMalinen, E., Rinttila, T., Kajander, K., Matto, J., Kassinen, A., Krogius, L., Saarela, M., Korpela, R., & Palva, A. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.40312.x · Cited by 699 · cited 7×
“, 2009), microarray-derived microbiota profiles (Rajilić-Stojanović, 2007) and qPCR assays (Lyra et al., 2009; Malinen et al., 2005; Tana et al., 2010) between IBS patients and HCs.”
BackgroundMethodResultInfluentialSelf-citationHigh-throughput diversity and functionality analysis of the gastrointestinal tract microbiota
Zoetendal, E. G., Rajilić-Stojanović, M., & de Vos, W. M. (2008) · Gut · doi:10.1136/gut.2007.133603 · Cited by 673
Khoruts, A., Dicksved, J., Jansson, J. K., & Sadowsky, M. J. (2010) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181c87e02 · Cited by 649 · cited 1×
“, 2007), and from an individual suffering from Clostridium difficile-associated disease (CDAD) with severe diarrhoea and colitis (Khoruts et al., 2010).”
BackgroundPimentel, M., Lin, H. C., Enayati, P., van den Burg, B., Lee, H.-R., Chen, J. H., Park, S., Kong, Y., & Conklin, J. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00574.2004 · Cited by 508 · cited 1×
“Despite the fact that methane (CH4), produced by methanogenic Archaea, has a proven causative and mechanistically described link to constipation (Pimentel et al., 2006), only a few studies have studied the methanogenic Archaea in IBS patients.”
Backgroundtana, C., umesaki, Y., imaoka, A., handa, T., kanazawa, M., & fukudo, S. (2009) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2009.01427.x · Cited by 474
Abnormal colonic fermentation in irritable bowel syndrome
King, T., Elia, M., & Hunter, J. (1998) · The Lancet · doi:10.1016/s0140-6736(98)02146-1 · Cited by 473 · cited 1×
“An initial study that suggested the role of H2 in IBS analysed the total excretion of colonic gas in six IBS patients, who showed elevated production of H2 on a fibrerich diet, although the total volume of gas did not differ when compared with the HCs (King et al., 1998).”
ResultAbsence of intestinal microbiota does not protect mice from diet-induced obesity
Fleissner, C. K., Huebel, N., Abd El-Bary, M. M., Loh, G., Klaus, S., & Blaut, M. (2010) · British Journal of Nutrition · doi:10.1017/s0007114510001303 · Cited by 436 · cited 1×
“, 2009) as well as high fat intake (Fleissner et al., 2010).”
BackgroundRome II: The functional gastrointestinal disorders
Mertz, H. (2001) · Gastroenterology · doi:10.1016/s0016-5085(01)83863-4 · Cited by 382
Liu, C., Finegold, S. M., Song, Y., & Lawson, P. A. (2008) · INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY · doi:10.1099/ijs.0.65208-0 · Cited by 358
Krogius-Kurikka, L., Lyra, A., Malinen, E., Aarnikunnas, J., Tuimala, J., Paulin, L., Mäkivuokko, H., Kajander, K., & Palva, A. (2009) · BMC Gastroenterology · doi:10.1186/1471-230x-9-95 · Cited by 308 · cited 12×
“Comparison of the 16S rDNA clone libraries between the IBS-D group and HCs pointed out several significant differences (Table 1; Krogius-Kurikka et al., 2009), confirming and extending the findings of Kassinen et al.”
InfluentialSelf-citationMättö, J., Maunuksela, L., Kajander, K., Palva, A., Korpela, R., Kassinen, A., & Saarela, M. (2005) · FEMS Immunology & Medical Microbiology · doi:10.1016/j.femsim.2004.08.009 · Cited by 301 · cited 4×
“Finally, the initial finding of the temporal instability of IBS patient microbiota (Mättö et al., 2005) should be readdressed by repeated sampling of patients to provide a longitudinal aspect for the structural and functional attributes of their microbiota.”
BackgroundMethodInfluentialSelf-citationKerckhoffs, A. P., Samsom, M., Rest, M. E. V. D., Vogel, J. D., Knol, J., Ben-Amor, K., & Akkermans, L. M. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.2887 · Cited by 289 · cited 3×
“catenulatum in the duodenal mucosa of IBS patients independently of the subgroup (Kerckhoffs et al., 2009).”
BackgroundResultA Molecular Analysis of Fecal and Mucosal Bacterial Communities in Irritable Bowel Syndrome
Codling, C., O’Mahony, L., Shanahan, F., Quigley, E. M. M., & Marchesi, J. R. (2010) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-0934-x · Cited by 243 · cited 2×
“Fingerprinting analysis to qualitatively characterize the mucosal microbiota has been employed in a small number of unsubtyped IBS patients (Codling et al., 2010) as well as in IBS-D patients in parallel to HCs (Carroll et al.”
BackgroundAssociation of symptoms with gastrointestinal microbiota in irritable bowel syndrome
Malinen, E. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i36.4532 · Cited by 218 · cited 1×
“Pilot studies correlating GI symptoms with the microbiota have recently been published (Malinen et al., 2010; Tana et al., 2010).”
BackgroundScanlan, P. D., Shanahan, F., & Marchesi, J. R. (2008) · BMC Microbiology · doi:10.1186/1471-2180-8-79 · Cited by 206 · cited 1×
“However, direct PCR-based enumeration of methanogens found no difference in their prevalence between the IBS and HC groups, in contrast to the significantly lowered incidence of these organisms in IBD patients (Scanlan et al., 2008).”
ResultMechanisms of Microbial Hydrogen Disposal in the Human Colon and Implications for Health and Disease
Nakamura, N., Lin, H. C., McSweeney, C. S., Mackie, R. I., & Gaskins, H. R. (2010) · Annual Review of Food Science and Technology · doi:10.1146/annurev.food.102308.124101 · Cited by 197 · cited 1×
“, 2010) and the different H2 disposal routes discussed above (Nakamura et al., 2010).”
BackgroundBourdu, S., Dapoigny, M., Chapuy, E., Artigue, F., Vasson, M.-P., Dechelotte, P., Bommelaer, G., Eschalier, A., & Ardid, D. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.082 · Cited by 176
Mucosal cytokine imbalance in irritable bowel syndrome
Macsharry, J., O'Mahony, L., Fanning, A., Bairead, E., Sherlock, G., Tiesman, J., Fulmer, A., Kiely, B., Dinan, T. G., Shanahan, F., et al. (2008) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520802276127 · Cited by 174 · cited 1×
“In addition, the presence of low-level inflammation in the GI mucosa of IBS patients has also been observed in several studies, including those reported by Aerssens et al. (2008), Chadwick et al. (2002) and Macsharry et al. (2008).”
ResultThe effects of butyrate enemas on visceral perception in healthy volunteers
Vanhoutvin, S. A. L. W., Troost, F. J., Kilkens, T. O. C., Lindsey, P. J., Hamer, H. M., Jonkers, D. M. A. E., Venema, K., & Brummer, R. ‐. M. (2009) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2009.01324.x · Cited by 171 · cited 1×
“Acetate is a known chemical irritant, and at high concentrations is used to induce mucosal lesions and abdominal cramps in experimental animals, while butyrate is considered as protective and able to dose-dependently reduce abdominal pain in humans in vivo (Vanhoutvin et al., 2009).”
BackgroundParkes, G. C., Brostoff, J., Whelan, K., & Sanderson, J. D. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01869.x · Cited by 167 · cited 1×
“This review focuses on recent GI microbiota research in IBS patients, with a special emphasis on mining the subtype-specific findings obtained using culture-independent methods, as the initial culture-based studies had various limitations and have already been thoroughly reviewed in the existing literature (Lee & Tack…”
MethodLyra, A., Rinttilä, T., Nikkilä, J., Krogius-Kurikka, L., Kajander, K., Malinen, E., Mättö, J., Mäkelä, L., & Palva, A. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.5936 · Cited by 160
Self-citationThe Neglected Organ: Bacterial Flora Has a Crucial Immunostimulatory Role
Bocci, V. (1992) · Perspectives in Biology and Medicine · doi:10.1353/pbm.1992.0004 · Cited by 159
Maukonen, J., Satokari, R., Mättö, J., Söderlund, H., Mattila-Sandholm, T., & Saarela, M. (2006) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46134-0 · Cited by 156 · cited 2×
“, 2005) were readdressed by excluding those patients who had recently received antibiotics (Maukonen et al., 2006).”
BackgroundTreem, W. R., Ahsan, N., Kastoff, G., & Hyams, J. S. (1996) · Journal of Pediatric Gastroenterology & Nutrition · doi:10.1097/00005176-199610000-00013 · Cited by 146 · cited 1×
“However, as IBS-D patients have also been documented to have more butyrate but less total SCFAs than HCs (Treem et al., 1996), and as butyrate induces visceral hypersensitivity in a rat model (Bourdu et al.”
BackgroundAlterations in mucosal immunity identified in the colon of patients with irritable bowel syndrome
Aerssens, J., Camilleri, M., Talloen, W., Thielemans, L., Göhlmann, H. W. H., Van den Wyngaert, I., Thielemans, T., De Hoogt, R., Andrews, C. N., Bharucha, A. E., et al. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2007.11.012 · Cited by 124
Isolation of flagellated bacteria implicated in Crohnʼs disease
Duck, W. L., Walter, M. R., Novak, J., Kelly, D., Tomasi, M., Cong, Y., & Elson, C. O. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20237 · Cited by 121 · cited 1×
“Representatives of the Lachnospiraceae express highly antigenic flagellins (Duck et al., 2007), which have been recognized as triggers of elevated immune reactivity in Crohn’s disease patients and a subset of IBS patients (Schoepfer et al.”
BackgroundAntibodies to flagellin indicate reactivity to bacterial antigens in IBS patients
Schoepfer, A. M., Schaffer, T., Seibold‐schmid, B., Müller, S., & Seibold, F. (2008) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2008.01166.x · Cited by 120 · cited 1×
“, 2007), which have been recognized as triggers of elevated immune reactivity in Crohn’s disease patients and a subset of IBS patients (Schoepfer et al., 2008).”
BackgroundCurrent insights in to the pathophysiology of Irritable Bowel Syndrome
Karantanos, T., Markoutsaki, T., Gazouli, M., Anagnou, N. P., & Karamanolis, D. G. (2010) · Gut Pathogens · doi:10.1186/1757-4749-2-3 · Cited by 97
Engelbrektson, A., Korzenik, J. R., Pittler, A., Sanders, M. E., Klaenhammer, T. R., Leyer, G., & Kitts, C. L. (2009) · Journal of Medical Microbiology · doi:10.1099/jmm.0.47615-0 · Cited by 94 · cited 1×
“A subset of healthy individuals without any intestinal complaints appear to carry unstable GI microbiota (Engelbrektson et al., 2009).”
BackgroundAlterations in the Intestinal Microbiota and Functional Bowel Symptoms
Ringel, Y., & Carroll, I. M. (2009) · Gastrointestinal Endoscopy Clinics of North America · doi:10.1016/j.giec.2008.12.004 · Cited by 73
Altered intestinal microbiota in irritable bowel syndrome: Microbiota in IBS
Lee, K. J., & Tack, J. (2010) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2010.01482.x · Cited by 69
The Metabolic Effects of 4-Aminopteroylglutamic Acid in the Guinea-Pig
Girdwood, R. H. (1951) · British Journal of Nutrition · doi:10.1079/bjn19510001 · Cited by 58
serra, J., villoria, A., azpiroz, F., lobo, B., santos, J., accarino, A., & malagelada, J.-R. (2010) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2009.01447.x · Cited by 57
Treating irritable bowel syndrome with probiotics: the evidence
Parkes, G. C., Sanderson, J. D., & Whelan, K. (2010) · Proceedings of the Nutrition Society · doi:10.1017/s002966511000011x · Cited by 57 · cited 1×
“This aspect has also been recently reviewed (Moayyedi et al., 2010; Parkes et al., 2010; Pimentel & Lezcano, 2007) and will not be further discussed in this review.”
BackgroundRajilic-Stojanovic, M. (2024) · doi:10.18174/2282 · Cited by 47 · cited 7×
“Application of the HITChip has allowed simultaneous detection and identification of over one thousand intestinal phylotypes in IBS patients and HCs (Rajilić-Stojanović, 2007).”
BackgroundMethodResultInfluentialIrritable bowel syndrome: Bacterial overgrowth—What’s known and what to do
Pimentel, M., & Lezcano, S. (2007) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-007-0076-1 · Cited by 37
Rana, S., Sharma, S., Sinha, S. K., Kaur, H., Sikander, A., & Singh, K. (2008) · Digestive Diseases and Sciences · doi:10.1007/s10620-008-0315-x · Cited by 30 · cited 1×
“Based on breath testing, both the prevalence and the rate of CH4 production were lower in unsubtyped IBS patients than in HCs (Rana et al., 2009).”
BackgroundReview: Do patients with functional gastrointestinal disorders have an altered gut flora?
Quigley, E. M. M. (2009) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x09335636 · Cited by 17 · cited 1×
“This review focuses on recent GI microbiota research in IBS patients, with a special emphasis on mining the subtype-specific findings obtained using culture-independent methods, as the initial culture-based studies had various limitations and have already been thoroughly reviewed in the existing literature (Lee & Tack…”
MethodCarroll, I. M., Keku, T. O., Ringel‐Kulka, T., Sartor, R. B., & Ringel, Y. (2010) · Gastroenterology · doi:10.1016/s0016-5085(10)62878-8 · Cited by 5 · cited 1×
“Fingerprinting analysis to qualitatively characterize the mucosal microbiota has been employed in a small number of unsubtyped IBS patients (Codling et al., 2010) as well as in IBS-D patients in parallel to HCs (Carroll et al., 2010).”
BackgroundCarroll, I. M., Shen, X., Keku, T. O., Sartor, R. B., & Ringel, Y. (2008) · Gastroenterology · doi:10.1016/s0016-5085(08)63180-7 · Cited by 3 · cited 1×
“On the other hand, untypically high faecal amounts of lactobacilli and/or streptococci have been reported for IBS-D patients (Kassinen et al., 2007; Krogius-Kurikka et al., 2009; Carroll et al., 2008) as well as IBS patients independent of the subtype (Tana et al., 2010).”
BackgroundChassard, C., Dapoigny, M. C., Scott, K. P., Del’Homme, C., Dubray, C., Eschalier, A., Flint, H. J., & Bernalier‐Donadille, A. (2009) · Gastroenterology · doi:10.1016/s0016-5085(09)60961-6 · Cited by 2 · cited 1×
“, the predominant SRB genus in the gut, while culture- and FISH-based analysis of IBS-C subjects showed significantly more SRB compared with HCs (Chassard et al., 2009).”
Result
Cited by
Rinninella, E., Raoul, P., Cintoni, M., Franceschi, F., Miggiano, G. A. D., Gasbarrini, A., & Mele, M. C. (2019) · Microorganisms · doi:10.3390/microorganisms7010014 · Cited by 3,462
“Other studies [62,65] confirmed and revealed some phyla and genera variations in IBS patients compared to healthy controls: an increase in the Firmicutes-to Bacteroidetes-ratio, a decrease in some Firmicutes families (Lactobacilli, Faecalibacterium) and the Actinobacteria population (Bifidobacteria, Collinsella), and…”
ResultDysbiosis of the gut microbiota in disease
Carding, S., Verbeke, K., Vipond, D. T., Corfe, B. M., & Owen, L. J. (2015) · Microbial Ecology in Health & Disease · doi:10.3402/mehd.v26.26191 · Cited by 1,710
“In IBS, changes in microbiota composition have been described in the different subtypes of disease compared to healthy individuals (38, 39) although the changes are not uniform (40).”
BackgroundThe interplay between the intestinal microbiota and the brain
Collins, S. M., Surette, M., & Bercik, P. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2876 · Cited by 1,611
Rajilić–Stojanović, M., Biagi, E., Heilig, H. G. H. J., Kajander, K., Kekkonen, R. A., Tims, S., & de Vos, W. M. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.07.043 · Cited by 1,041
Intestinal microbiota in functional bowel disorders: a Rome foundation report
Simrén, M., Barbara, G., Flint, H. J., Spiegel, B. M. R., Spiller, R. C., Vanner, S., Verdu, E. F., Whorwell, P. J., & Zoetendal, E. G. (2013) · Gut · doi:10.1136/gutjnl-2012-302167 · Cited by 939
Metadata
- Authors
- Salonen, A., de Vos, W. M., & Palva, A.
- Affiliations
- University of Helsinki (FI)
- Laboratory of Microbiology, Wageningen University, Dreijenplein 10, 6703 HB Wageningen, The Netherlands
- ORCID
- Salonen, Anne
- Venue
- Microbiology
- Publisher
- Microbiology Society
- Published
- 2010-11-01
- Volume
- 156
- Issue
- 11
- Pages
- 3205-3215
- ISSN
- 1350-0872 (ISSN-L)
- 1465-2080
- OpenAlex
- W2118173539
- Cited by
- 264
- References
- 59
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 7 · 2023: 11 · 2022: 8 · 2021: 20 · 2020: 16 · 2019: 11 · 2018: 8 · 2017: 18 · 2016: 21 · 2015: 20 · 2014: 31 · 2013: 29 · 2012: 30
- FWCI
- 2.41
- Type
- journal article
- Language
- en
- Open access
- green
- research.wur.nl
- Licence
- cc-by
- Locations
- Microbiology (publishedVersion)
- PubMed (publishedVersion)
- Socio-Environmental Systems Modeling (acceptedVersion, cc-by)
- Data Archiving and Networked Services (DANS) (submittedVersion, cc-by)
- Funders
- Tekes
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Gastroenterology › Microscopic Colitis
- Keywords
- irritable bowel syndrome, gut microbiota, dysbiosis, functional gastrointestinal disorders, Rome criteria, microbial biomarkers, IBS diagnosis, molecular microbiology
- MeSH terms
- Bacteria, DNA, Bacterial, Feces, Humans, Phylogeny, Biomarkers, Gastrointestinal Tract, Irritable Bowel Syndrome, Metagenome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.